What are the latest funding news in the healthcare AI market? (September 2026)
Download our beautiful pitch about the healthcare AI market
In our healthcare AI market deck, you will find everything you need to understand the market
The 12 healthcare AI companies tracked here announced approximately $205.1M in funding between July 9 and September 1, 2026.
The rounds covered provider operations, clinical trials, diagnostics, medical imaging, behavioral health, connected devices, and AI-native drug discovery.
Every company in this selection builds technology specifically for healthcare customers rather than selling general-purpose AI software.
And if you want to better understand this new industry, you can download our pitch covering the healthcare AI market.
Insights
- The 12 disclosed healthcare AI rounds totalled about $205.1M, but the three largest financings, MindRank, Faro, and Arintra, represented roughly 56% of the capital raised.
- Life sciences AI attracted $89.3M across Faro and MindRank alone, showing that clinical development and AI drug discovery remained major healthcare AI funding categories.
- Provider operations attracted about $81.3M across Norbert Health, Onos Health, Arintra, Hike Medical, and MiiHealth AI, with workflow automation appearing across both clinical and administrative settings.
- Only six of the 12 healthcare AI financings used a conventional Series A or Series B label, while the rest were seed, pre-seed, mixed-stage, or unspecified growth financings.
- Diagnostics and imaging companies, including TidalSense, CARPL.ai, and Eyedentity, raised about $30.5M, highlighting continued investor interest in AI that supports clinical decisions from sensor and image data.
- Four European healthcare AI companies raised funding in this group, showing that healthcare AI deal activity was not limited to the United States despite the strong U.S. provider-software pipeline.
- No valuation was publicly disclosed for any of the 12 deals, a reminder that healthcare AI fundraising news often reveals operating momentum but not pricing benchmarks.
As this chart shows, and as featured in our healthcare AI market deck, search interest in healthcare AI has grown rapidly
Summary table of the latest funding deals in the healthcare AI market as of September 2026
We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.
We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.
We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.
You can also read our detailed analysis to understand how funding activity in the healthcare AI market has evolved over the last few years.
We also have a quarter-by-quarter analysis of funding activity in the market here.
Finally, you can check our complete list of fundraising deals for the healthcare AI market (we update this list every quarter) as well as our ranking of the most funded startups.
| Name | When | Amount in $ | Round Type | Category |
|---|---|---|---|---|
| MindRank AI | July 9, 2026 | $52M | Series B | AI Drug Discovery & Biotech R&D |
| CARPL.ai | July 23, 2026 | $10M | Series A | Radiology AI & Clinical Imaging Infrastructure |
| TidalSense | July 24, 2026 | $19M | Growth Financing | AI Diagnostics & Connected Medical Devices |
| MiiHealth AI | August 14, 2026 | $2.8M | Seed | Patient Intake & Clinical Documentation |
| Aisel Health | August 19, 2026 | Approx. $2M | Pre-seed | Psychiatric Workflow & Clinical Documentation |
| Eyedentity | August 21, 2026 | Approx. $1.5M | Seed | Ophthalmology AI & Cancer Diagnostics |
| Clementine | August 24, 2026 | $2M | Seed | Hearing Care & Patient Engagement |
| Hike Medical | August 25, 2026 | $22.5M | Seed & Series A | Medical Device Workflow & DME Automation |
| Onos Health | August 26, 2026 | $17M | Series A | Payer Analytics & Behavioral Health Intelligence |
| Arintra | August 26, 2026 | $25M | Series B | Revenue Cycle Automation & Medical Coding |
| Faro AI | August 26, 2026 | $37.3M | Series B | Clinical Trials & Clinical Development AI |
| Norbert Health | September 1, 2026 | $14M | Series A | Care Delivery Robotics & Patient Monitoring |
All the latest funding deals in the healthcare AI market as of September 2026
Norbert Health raised $14M in September 2026. ([prnewswire.com](https://www.prnewswire.com/news-releases/norbert-health-raises-14-million-series-a-to-power-autonomous-robotic-nursing-assistants-302865486.html?utm_source=openai))
When was it?
Norbert Health announced the Series A on September 1, 2026.
Who are they?
Norbert Health provides clinical AI that enables robots to round on patients, monitor residents, document observations, and alert care teams.
Geographical focus?
Norbert Health is focused primarily on U.S. skilled-nursing and rehabilitation facilities.
Why do we include them in the healthcare AI market?
Norbert Health belongs in healthcare AI because its physical AI platform supports care-delivery robotics, monitoring, and clinical workflow automation.
What is the company stage?
Norbert Health is at an early commercial growth stage, with its system already deployed in live care facilities.
How much did they raise?
Norbert Health raised $14M in this financing round.
What round is it?
Norbert Health completed a Series A round.
Why did they raise?
Norbert Health raised the capital to expand its clinical skills library and deploy more autonomous nursing assistants.
Faro AI raised $37.3M in August 2026. ([axios.com](https://www.axios.com/newsletters/axios-pro-rata-348b8ec6-f9a1-4bca-9f25-c7880cfa1e5c?utm_source=openai))
When was it?
Faro AI announced the financing on August 26, 2026.
Who are they?
Faro AI provides biopharma teams with AI software for clinical-study design, protocol development, trial operations, and regulatory work.
Geographical focus?
Faro AI serves global pharmaceutical customers and is based in San Diego, California.
Why do we include them in the healthcare AI market?
Faro AI belongs in healthcare AI because its product is designed specifically for clinical development and clinical-trial workflows.
What is the company stage?
Faro AI is in a growth stage, with the company reporting use by six of the world’s ten largest pharmaceutical companies.
How much did they raise?
Faro AI raised $37.3M in the round.
What round is it?
Faro AI completed a Series B financing.
Why did they raise?
Faro AI raised the capital to expand agentic AI capabilities across connected clinical-development workflows.
This chart, featured in our healthcare AI market deck, compares the main business model options for ambient AI companies
Onos Health raised $17M in August 2026. ([onoshealth.com](https://onoshealth.com/news/onos-series-a-announcement/?utm_source=openai))
When was it?
Onos Health announced the financing on August 26, 2026.
Who are they?
Onos Health analyzes payer data and behavioral-health documentation to identify care gaps, measure provider quality, and support earlier interventions.
Geographical focus?
Onos Health serves U.S. health plans, including national and regional payers.
Why do we include them in the healthcare AI market?
Onos Health belongs in healthcare AI because its platform provides payer analytics and behavioral-health clinical intelligence.
What is the company stage?
Onos Health is in early growth, with deployments across several large U.S. health plans.
How much did they raise?
Onos Health raised $17M in the financing.
What round is it?
Onos Health completed a Series A round.
Why did they raise?
Onos Health raised the capital to expand adoption among health plans and broaden its behavioral-health intelligence platform.
Arintra raised $25M in August 2026. ([prnewswire.com](https://www.prnewswire.com/news-releases/arintra-raises-25m-to-pioneer-revenue-assurance-for-americas-health-systems-302860106.html?utm_source=openai))
When was it?
Arintra announced its funding round on August 26, 2026.
Who are they?
Arintra uses AI to review clinical documentation, assign medical codes, and improve revenue assurance for hospitals and health systems.
Geographical focus?
Arintra is focused primarily on U.S. hospitals and health systems.
Why do we include them in the healthcare AI market?
Arintra belongs in healthcare AI because its platform automates medical coding and revenue-cycle operations for providers.
What is the company stage?
Arintra is at a growth stage, with deployments across multiple health systems and more than 23 specialties.
How much did they raise?
Arintra raised $25M, bringing its total disclosed funding to about $51M.
What round is it?
Arintra completed a Series B round.
Why did they raise?
Arintra raised the capital to expand across health systems and scale AI-powered revenue-cycle automation.
This chart, featured in our healthcare AI market deck, looks at Tempus AI’s strategy in healthcare AI
Hike Medical raised $22.5M in August 2026. ([wkow.marketminute.com](https://wkow.marketminute.com/article/bizwire-2026-8-25-hike-medical-raises-225m-to-modernize-the-medical-device-supply-chain-from-referral-to-device-delivery?utm_source=openai))
When was it?
Hike Medical announced the financing on August 25, 2026.
Who are they?
Hike Medical automates referrals, insurance approvals, clinical documentation, manufacturing, and delivery for orthotics, prosthetics, and durable medical equipment.
Geographical focus?
Hike Medical operates in the United States, with San Francisco operations and Illinois manufacturing.
Why do we include them in the healthcare AI market?
Hike Medical belongs in healthcare AI because it uses AI agents to automate medical-device care and durable-medical-equipment workflows.
What is the company stage?
Hike Medical is in early commercial growth, with active customers and an operating manufacturing platform.
How much did they raise?
Hike Medical raised $22.5M across the financing.
What round is it?
Hike Medical raised a combined seed and Series A financing.
Why did they raise?
Hike Medical raised the capital to expand manufacturing capacity, hire staff, and enter more device categories.
Clementine raised $2M in August 2026. ([ai.askclementine.com](https://ai.askclementine.com/news?utm_source=openai))
When was it?
Clementine announced the seed round on August 24, 2026.
Who are they?
Clementine provides hearing-care clinics with an AI agent that answers patient questions and helps convert enquiries into appointments.
Geographical focus?
Clementine is focused on European hearing-care providers, especially in the Netherlands and nearby markets.
Why do we include them in the healthcare AI market?
Clementine belongs in healthcare AI because its product is purpose-built for patient engagement and access workflows in hearing care.
What is the company stage?
Clementine is at an early commercial stage and is scaling a focused clinic product.
How much did they raise?
Clementine raised $2M in the financing.
What round is it?
Clementine completed a seed round.
Why did they raise?
Clementine raised the capital to scale its AI hearing-activation platform for clinics.
In our healthcare AI market deck, we identify pain points entrepreneurs should prioritize
Eyedentity raised about $1.5M in August 2026. ([eu-startups.com](https://www.eu-startups.com/2026/08/stockholm-based-eyedentity-secures-e1-3-million-to-detect-deadly-eye-cancer-earlier-with-ai/?utm_source=openai))
When was it?
Eyedentity announced the investment on August 21, 2026.
Who are they?
Eyedentity develops AI that analyzes fundus images to help eye-care professionals detect ocular cancer earlier.
Geographical focus?
Eyedentity is based in Stockholm and is focused on Sweden and the broader European market.
Why do we include them in the healthcare AI market?
Eyedentity belongs in healthcare AI because it develops medical-imaging AI for ophthalmology and cancer diagnostics.
What is the company stage?
Eyedentity is at a pre-commercial and regulatory-validation stage.
How much did they raise?
Eyedentity raised €1.3M, or approximately $1.5M.
What round is it?
Eyedentity described the financing as its first oversubscribed investment round, commonly classified as seed funding.
Why did they raise?
Eyedentity raised the capital for regulatory approval, product development, and expansion into opticians, clinics, and hospitals.
Aisel Health raised about $2M in August 2026. ([24victoria.dk](https://24victoria.dk/ivaerksaetteri/aisel-health-rejser-17-mio-euro?utm_source=openai))
When was it?
Aisel Health announced the pre-seed round on August 19, 2026.
Who are they?
Aisel Health provides psychiatric clinics with an AI operating system that surfaces useful patient context before, during, and after consultations.
Geographical focus?
Aisel Health began in Denmark and is preparing to expand into the United Kingdom.
Why do we include them in the healthcare AI market?
Aisel Health belongs in healthcare AI because its platform automates psychiatric-clinic workflows and organizes clinical documentation.
What is the company stage?
Aisel Health is at an early commercial stage, with a developing clinic pipeline and planned U.K. expansion.
How much did they raise?
Aisel Health raised €1.7M, or approximately $2M.
What round is it?
Aisel Health completed a pre-seed round.
Why did they raise?
Aisel Health raised the capital to grow its clinical and engineering teams and fund its U.K. market entry.
This market map, featured in our healthcare AI market deck, highlights top companies and startups in the healthcare AI market
MiiHealth AI raised $2.8M in August 2026. ([bizjournals.com](https://www.bizjournals.com/phoenix/news/2026/08/14/miihealth-raises-seed-round.html?utm_source=openai))
When was it?
MiiHealth AI’s seed round was publicly reported on August 14, 2026.
Who are they?
MiiHealth AI provides a multilingual patient-intake assistant that collects information before appointments and prepares structured context for clinicians.
Geographical focus?
MiiHealth AI is focused on U.S. outpatient providers and is based in Phoenix, Arizona.
Why do we include them in the healthcare AI market?
MiiHealth AI belongs in healthcare AI because it supports patient intake, clinical documentation, and provider workflow automation.
What is the company stage?
MiiHealth AI is moving from MVP into early commercialization through pilots, integrations, and specialty expansion.
How much did they raise?
MiiHealth AI raised $2.8M in seed funding.
What round is it?
MiiHealth AI completed a seed round.
Why did they raise?
MiiHealth AI raised the capital to build its engineering team, deepen EHR integrations, and expand commercial deployment.
TidalSense raised $19M in July 2026. ([mobihealthnews.com](https://www.mobihealthnews.com/news/tidalsense-raises-19m-improve-copd-diagnostics?utm_source=openai))
When was it?
TidalSense announced the financing on July 24, 2026.
Who are they?
TidalSense combines a handheld breathing sensor with AI to identify COPD from a short normal-breathing test.
Geographical focus?
TidalSense is commercializing in the United Kingdom, Ireland, and Europe while preparing for U.S. market entry.
Why do we include them in the healthcare AI market?
TidalSense belongs in healthcare AI because it combines a connected medical device with AI-powered respiratory diagnostics.
What is the company stage?
TidalSense is at a commercialization and growth stage, with a CE-marked device already used in U.K. care settings.
How much did they raise?
TidalSense raised $19M in the financing.
What round is it?
TidalSense described the transaction as a funding round without assigning a Series label.
Why did they raise?
TidalSense raised the capital to expand European commercialization, prepare for U.S. entry, and develop additional respiratory tests.
This chart, featured in our healthcare AI market deck, shows annual funding in healthcare AI startups
CARPL.ai raised $10M in July 2026. ([carpl.ai](https://carpl.ai/news/carplai-raises-10mn-led-by-ifc-to-accelerate-healthcare-ai-adoption-globally?utm_source=openai))
When was it?
CARPL.ai announced the Series A on July 23, 2026.
Who are they?
CARPL.ai gives hospitals and radiology groups a platform to deploy, manage, compare, and monitor medical-imaging AI applications.
Geographical focus?
CARPL.ai serves healthcare providers globally, with product and engineering roots in India.
Why do we include them in the healthcare AI market?
CARPL.ai belongs in healthcare AI because it provides clinical infrastructure for radiology AI deployment and imaging workflows.
What is the company stage?
CARPL.ai is at a growth stage, with an established enterprise platform and international provider adoption.
How much did they raise?
CARPL.ai raised $10M in the round.
What round is it?
CARPL.ai completed a Series A financing.
Why did they raise?
CARPL.ai raised the capital to expand product development, grow its partner ecosystem, and accelerate global commercial growth.
MindRank AI raised $52M in July 2026. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/07/10/3325291/0/en/mindrank-announces-52-million-series-b-financing.html?utm_source=openai))
When was it?
MindRank AI announced the Series B financing on July 9, 2026.
Who are they?
MindRank AI uses AI, computational chemistry, experimental evidence, and clinical learning to discover and develop new medicines.
Geographical focus?
MindRank AI is focused initially on China, with drug-development ambitions for global markets.
Why do we include them in the healthcare AI market?
MindRank AI belongs in healthcare AI because it is an AI-native biotech company focused on drug discovery and pharmaceutical R&D.
What is the company stage?
MindRank AI is at a clinical growth stage, with its oral GLP-1 candidate MDR-001 in Phase III development in China.
How much did they raise?
MindRank AI raised $52M in the financing.
What round is it?
MindRank AI completed a Series B round.
Why did they raise?
MindRank AI raised the capital to advance its AI-native research engine and progress its clinical and preclinical medicine pipeline.
Related blog posts
- How funding activity has changed in healthcare AI
- What are the latest fundraising trends in healthcare AI?
- How strong is fundraising in the healthcare AI market right now?
- Healthcare AI: who are the top startups?
